Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Novo Nordisk A/S ADR (NVO)

95.16   -0.28 (-0.29%) 01-26 00:16
Open: 94.19 Pre. Close: 95.44
High: 95.87 Low: 93.99
Volume: 2,575,469 Market Cap: 216,755M
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Lund University to develop treatment for Parkinson's diseases; and bluebird bio, Inc. to develop genome editing treatments for children and adult patients. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 95.992 - 96.458 96.458 - 96.918
Low: 92.608 - 93.197 93.197 - 93.777
Close: 94.063 - 95.002 95.002 - 95.928

Technical analysis

as of: 2022-01-25 4:26:03 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 122.34     One year: 131.88
Support: Support1: 91.52    Support2: 76.14
Resistance: Resistance1: 104.74    Resistance2: 112.91
Pivot: 99.18
Moving Average: MA(5): 95.74     MA(20): 102.10
MA(100): 105.38     MA(250): 90.82
MACD: MACD(12,26): -3.77     Signal(9): -3.20
Stochastic oscillator: %K(14,3): 15.81     %D(3): 9.30
RSI: RSI(14): 28.81
52-week: High: 117.35  Low: 66.59  Change(%): 36.7
Average Vol(K): 3-Month: 1317  10-Days: 1677

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NVO has closed above bottom band by 20.1%. Bollinger Bands are 17.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 10 Jan 2022
Novo Nordisk A/S – Share repurchase programme - GlobeNewswire

Mon, 10 Jan 2022
My Nifty 50 Stock Portfolio - Seeking Alpha

Fri, 17 Dec 2021
Novo Nordisk cites supply issues in the U.S. for weight loss therapy - Seeking Alpha

Mon, 13 Dec 2021
NVO (Novo Nordisk A/S ADR) -

Fri, 26 Nov 2021
Novo Nordisk announces impact from Volume Based Procurement - GlobeNewswire

Thu, 18 Nov 2021
Novo Nordisk Agrees to Buy Dicerna Pharma for $3.3 Billion - TheStreet

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 2,280
Shares Float (M) 1,630
% Held by Insiders 0.01
% Held by Institutions 7.75
Shares Short (K) 2,810
Shares Short P. Month (K) 1,910

Stock Financials

EPS 3.070
EPS Est This Year 2.420
EPS Est Next Year 2.590
Book Value (p.s.) 28.850
Profit Margin 34.31
Operating Margin 42.00
Return on Assets (ttm) 22.5
Return on Equity (ttm) 73.5
Qtrly Rev. Growth 15.2
Gross Profit (p.s.) 46.496
Sales Per Share 59.035
EBITDA (p.s.) 26.500
Qtrly Earnings Growth 17.70
Operating Cash Flow (M) 58,190
Levered Free Cash Flow (M) 32,650

Stock Valuations

PE Ratio 31.00
PEG Ratio
Price to Book value 3.30
Price to Sales 1.61
Price to Cash Flow

Stock Dividends

Dividend 9.350
Forward Dividend 1.470
Dividend Yield 0.10
Dividend Pay Date 2021-08-24
Ex-Dividend Date 2021-08-15
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.